IRIS
DEGIACOMI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.753
AS - Asia 1.164
EU - Europa 960
SA - Sud America 197
Continente sconosciuto - Info sul continente non disponibili 141
AF - Africa 69
OC - Oceania 3
Totale 4.287
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.683
CN - Cina 357
SG - Singapore 295
IE - Irlanda 245
VN - Vietnam 165
HK - Hong Kong 161
RU - Federazione Russa 152
BR - Brasile 150
IT - Italia 118
DE - Germania 111
FI - Finlandia 79
FR - Francia 69
GB - Regno Unito 52
ZA - Sudafrica 48
IN - India 45
CA - Canada 37
UA - Ucraina 29
JP - Giappone 23
MX - Messico 22
BD - Bangladesh 19
SE - Svezia 19
AT - Austria 16
PL - Polonia 14
TR - Turchia 14
IQ - Iraq 13
BE - Belgio 11
CO - Colombia 11
VE - Venezuela 11
ES - Italia 10
NL - Olanda 8
PK - Pakistan 8
AR - Argentina 7
EC - Ecuador 7
UZ - Uzbekistan 7
CZ - Repubblica Ceca 6
ID - Indonesia 6
PH - Filippine 6
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
IL - Israele 4
KR - Corea 4
TW - Taiwan 4
AO - Angola 3
AU - Australia 3
CL - Cile 3
CR - Costa Rica 3
HU - Ungheria 3
KG - Kirghizistan 3
LT - Lituania 3
LV - Lettonia 3
MA - Marocco 3
MY - Malesia 3
NG - Nigeria 3
OM - Oman 3
PE - Perù 3
RO - Romania 3
TN - Tunisia 3
DO - Repubblica Dominicana 2
EG - Egitto 2
GR - Grecia 2
LB - Libano 2
NP - Nepal 2
TH - Thailandia 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CH - Svizzera 1
CM - Camerun 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GM - Gambi 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
MD - Moldavia 1
MG - Madagascar 1
NA - Namibia 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 4.147
Salva come PNG Salva come JPEG
Città #
Dublin 245
San Jose 217
Chandler 185
Ashburn 180
Singapore 159
Hong Kong 150
Dallas 113
Beijing 93
Boardman 76
Council Bluffs 72
Los Angeles 64
Ho Chi Minh City 56
Helsinki 52
Munich 49
Pavia 48
Hanoi 43
Johannesburg 43
New York 43
Lauterbourg 41
Jacksonville 37
Nanjing 36
Shanghai 31
Lawrence 30
Medford 30
Princeton 30
Moscow 28
Santa Clara 28
Tokyo 21
Redondo Beach 20
Orem 17
Wilmington 17
Columbus 16
São Paulo 15
Buffalo 14
The Dalles 14
Turku 14
Vienna 13
Nanchang 12
Warsaw 12
Chicago 11
Frankfurt am Main 10
London 10
Montreal 10
Nuremberg 10
Changsha 9
Chennai 9
Haiphong 9
Mexico City 9
Milan 9
Ottawa 9
Phoenix 9
Shenyang 9
Ann Arbor 8
Hangzhou 8
Piscataway 8
Stockholm 8
Brussels 7
Jiaxing 7
Paris 7
San Francisco 7
San Genesio ed Uniti 7
Biên Hòa 6
Boston 6
Cinisello Balsamo 6
Falkenstein 6
Hebei 6
Hyderabad 6
New Delhi 6
Olomouc 6
Tashkent 6
Toronto 6
Washington 6
Atlanta 5
Charlotte 5
Chongqing 5
Da Nang 5
Houston 5
Istanbul 5
Manchester 5
Mumbai 5
Tianjin 5
Birmingham 4
Brooklyn 4
Bến Tre 4
Caracas 4
Erbil 4
Medellín 4
Naples 4
Rio de Janeiro 4
Seattle 4
Woodbridge 4
Achel 3
Amsterdam 3
Bishkek 3
Brasília 3
Curitiba 3
Dearborn 3
Denver 3
Draper 3
Fairfield 3
Totale 2.732
Salva come PNG Salva come JPEG
Nome #
Biological and structural characterization of theMycobacterium smegmatis nitroreductase NfnB, and its rolein benzothiazinone resistance 165
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis 160
Clinical Isolates of Mycobacterium tuberculosis in Four European Hospitals are Uniformly Susceptible to Benzothiazinones 147
A phenotypic based target screening approach delivers new antitubercular CTP synthetase inhibitors 144
Decaprenylphosphoryl-beta-D-ribose 2’-epimerase from Mycobacterium tuberculosis is a magic drug target. 133
Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis. 132
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK 128
A New Benzothiazolthiazolidine Derivative, 11726172, Is Active In Vitro, In Vivo, and against Nonreplicating Cells of Mycobacterium tuberculosis 125
A Coumarin-Based Analogue of Thiacetazone as Dual Covalent Inhibitor and Potential Fluorescent Label of HadA in Mycobacterium tuberculosis 120
Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG. 115
New insights into the mechanism of action of the thienopyrimidine antitubercular prodrug TP053 114
CanB, a Druggable Cellular Target in Mycobacterium tuberculosis 112
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug 112
Pyridine-2-thiol 1-oxide derivatives and their use for treatment of mammalian infections caused by Mycobacterium or fungi 111
Design and Synthesis of Pyrano[3,2-b]indolones Showing Antimycobacterial Activity 111
Design of Anti-infectious Agents from Lawsone in a Three-Component Reaction with Aldehydes and Isocyanides 105
First triclosan-based macrocyclic inhibitors of InhA enzyme 104
Functional investigation of the antitubercular drug target Decaprenylphosphoryl-β-D-ribofuranose-2-epimerase DprE1/DprE2 complex 102
Mycobacterium tuberculosis Sulfate Ester Dioxygenase Rv3406 Is Able to Inactivate the RCB18350 Compound. 98
Nitric oxide-releasing compounds for the treatment of lung infections 95
GarA is an essential regulator of metabolism in mycobacterium tuberculosis 94
Protocol to quantify bacterial burden in time-kill assays using colony-forming units and most probable number readouts for Mycobacterium tuberculosis. 89
Age-related changes in PD-1 expression coincide with increased cytotoxic potential in Vδ2 T cells during infancy 85
The antimalarial mefloquine shows activity against mycobacterium abscessus, inhibiting mycolic acid metabolism 83
Promoter mutagenesis for fine-tuning expression of essential genes in Mycobacterium tuberculosis 83
Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options 80
Distinct Effects of Moxifloxacin and Bedaquiline on Growing and 'Non-Culturable' Mycobacterium abscessus 79
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit-to-lead optimization and release of a novel antitubercular chemotype via scaffold derivatization 78
Concomitant assessment of PD-1 and CD56 expression identifies subsets of resting cord blood Vδ2 T cells with disparate cytotoxic potential 78
In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates. 78
Essentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression 78
The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division. 74
Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients. 74
Implementing best practices on data generation and reporting of Mycobacterium tuberculosis in vitro assays within the ERA4TB consortium 73
The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme 73
The phosphatidyl-myo-inositol mannosyltransferase PimA is essential for Mycobacterium tuberculosis growth in vitro and in vivo 69
Exploring the plasticity of the InhA substrate-binding site using new diaryl ether inhibitors 66
Micrococcin P1 – A bactericidal thiopeptide active against Mycobacterium tuberculosis 65
Imidazoquinoline Derivatives as Potential Inhibitors of InhA Enzyme and Mycobacterium tuberculosis 63
The antibacterial prodrug activator Rv2466c is a mycothiol-dependent reductase in the oxidative stress response of Mycobacterium tuberculosis 60
P146 New weapons are necessary to fight Mycobacterium abscessus 59
Mechanochemical Studies on Coupling of Hydrazines and Hydrazine Amides with Phenolic and Furanyl Aldehydes—Hydrazones with Antileishmanial and Antibacterial Activities 54
New Drugs and Novel Cellular Targets against Tuberculosis 51
PknG senses amino acid availability to control metabolism and virulence of Mycobacterium tuberculosis 51
Promiscuous Targets for Antitubercular Drug Discovery: The Paradigm of DprE1 and MmpL3 50
Whole cell screen based identification of spiropiperidines with potent antitubercular properties 43
Uncovering insights into the biology of Mycobacterium tuberculosis using genetic tools 18
In vitro characterization of GSK2556286 in combination with bedaquiline and pretomanid against Mycobacterium tuberculosis 3
Rational Design of Diaryl Ether-Based Dual Inhibitors Targeting Successive Essential Enzymes HadAB and InhA in Mycobacterium tuberculosis. 3
Totale 4.287
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.381
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.381
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022136 0 1 1 0 2 2 5 14 8 5 14 84
2022/2023598 47 54 7 33 42 59 1 34 293 7 10 11
2023/2024300 50 52 8 16 18 54 12 28 5 15 26 16
2024/2025827 22 47 31 7 31 73 48 40 207 40 104 177
2025/20262.000 127 125 208 228 258 91 369 97 221 138 73 65
2026/202786 24 62 0 0 0 0 0 0 0 0 0 0
Totale 4.287